Astal Laboratories promoter ACESO buys 25,417 shares on BSE

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • ACESO Research Labs LLP bought 25,417 Astal Laboratories shares
  • Transaction valued at ₹19,99,812 executed on BSE
  • Purchase period spanned August 24 to September 8, 2026
  • Promoter holding rose to 2,011,012 equity shares
  • No derivative trading reported by the promoter
powered bylight_fuzz_icon
50667259

*this image is generated using AI for illustrative purposes only.

Astal Laboratories disclosed a share purchase by its promoter, ACESO Research Labs LLP, under SEBI’s insider trading regulations. The transaction reflects increased promoter confidence in the listed entity.

Transaction Details

ACESO Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Limited on the Bombay Stock Exchange (BSE). The purchase was executed in the open market between August 24, 2026 and September 8, 2026. The total value of the transaction stood at ₹19,99,812, excluding taxes and brokerage charges.

The acquisition increased ACESO’s total holding to 2,011,012 equity shares. Prior to this transaction, the promoter held 1,985,595 shares.

Metric Details
Promoter Entity ACESO Research Labs LLP
Shares Purchased 25,417
Transaction Value ₹19,99,812
Execution Window August 24, 2026 – September 8, 2026
Exchange BSE
Post-Transaction Holding 2,011,012 shares

Regulatory Disclosure

The company filed the disclosure with the BSE on September 11, 2026, pursuant to Regulation 7(2)(b) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Mahendra Kumar, Company Secretary and Compliance Officer of Astal Laboratories, signed the intimation letter.

Ravikanti Shailaja, Designated Partner of ACESO Research Labs LLP, submitted Form C to the Board of Directors on September 10, 2026. The form confirmed that no derivatives trading occurred in the company’s securities during this period.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.53%-4.08%-6.39%-2.27%-6.45%0.0%

Will this open-market purchase signal the start of a larger accumulation phase by ACESO Research Labs LLP in the coming quarters?

How might this increase in promoter holding influence Astal Laboratories' stock liquidity and trading volume on the BSE?

Are there any upcoming operational milestones or financial results that could justify the promoter's increased confidence at this specific time?

Astal Laboratories schedules 33rd AGM for September 29, 2026

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Astal Laboratories schedules its 33rd AGM for September 29, 2026
  • Remote e-voting window opens on September 26 and closes on September 28
  • Board approved FY26 financial results in September 4 meeting
  • Share transfer books close from September 23 to September 29
powered bylight_fuzz_icon
49727434

*this image is generated using AI for illustrative purposes only.

Astal Laboratories has scheduled its 33rd Annual General Meeting for September 29, 2026. The meeting will be held via video conference or other audio-visual means.

The company confirmed that shareholders can cast their votes electronically between September 26 and September 28, 2026. The board previously approved the financial results for FY26 during its session on September 4, 2026.

Key Outcomes

The board approved several key governance and compliance items during its session.

Agenda Item Status / Details
Financial Results Approved for FY ended March 31, 2026
Cost Auditor M/s Avnesh Jain & Co. appointed for FY27
AGM Date September 29, 2026, at 1:30 pm
Voting Mode Video Conferencing / OAVM
Scrutinizer M/s Mahendra Khandelwal & Co. appointed

E-Voting Schedule

Shareholders eligible to vote must be on the register of members as of the cut-off date, Tuesday, September 22, 2026. The remote e-voting process begins on Saturday, September 26, 2026, at 9:00 am and concludes on Monday, September 28, 2026, at 5:00 pm.

AGM Logistics

The 33rd Annual General Meeting is scheduled for Tuesday, September 29, 2026, at 1:30 pm. The register of members and share transfer books will remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026.

M/s Mahendra Khandelwal & Co., Practicing Company Secretary, was appointed as the scrutinizer to oversee remote e-voting and e-voting during the AGM.

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Astal Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.53%-4.08%-6.39%-2.27%-6.45%0.0%

What key strategic initiatives or capital allocation plans is Astal Laboratories' management expected to announce or discuss at the AGM that could impact shareholder value?

How have Astal Laboratories' FY26 financial results compared to industry peers, and what does this signal about the company's competitive positioning going into FY27?

Will the appointment of M/s Avnesh Jain & Co. as Cost Auditor for FY27 lead to any significant changes in the company's cost structure or operational efficiency strategies?

More News on Astal Laboratories

1 Year Returns:-6.45%